BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Engineering Events - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Engineering Events
X-ORIGINAL-URL:https://seasevents.nmsdev7.com
X-WR-CALDESC:Events for Penn Engineering Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221103T153000
DTEND;TZID=America/New_York:20221103T163000
DTSTAMP:20260405T121513
CREATED:20220812T144510Z
LAST-MODIFIED:20220812T144510Z
UID:7093-1667489400-1667493000@seasevents.nmsdev7.com
SUMMARY:BE Seminar: "Precision Engineering for Cancer Immunotherapy" (James Moon\, University of Michigan)
DESCRIPTION:This is a hybrid seminar which will be held in Glandt Forum (Singh Center) and via Zoom (link coming soon). \nPrecision Engineering for Cancer Immunotherapy \nCancer immunotherapy is now considered the fourth pillar of cancer therapy\, joining the ranks of surgery\, radiotherapy\, and chemotherapy. However\, only a small subset of cancer patients responds to cancer immunotherapy. Thus\, new approaches are needed to amplify anti-tumor immunity\, to convert cold tumor into hot tumor\, and to potentiate immunotherapies with minimal immune-related adverse events. The gut microbiome has recently emerged as the next frontier in drug development; however\, it remains unclear how to effectively alter gut microbiota for treating various diseases\, including cancer. Here\, we present new biomaterial-based strategies for altering the gut microbiome and improving the safety and efficacy of cancer immunotherapy. We are developing new dietary fiber-based biomaterials for in situ modulation of the gut microbiome for augmenting local and systemic immune responses. We will present the therapeutic potential of our gut modulation approach in the context of improving the efficacy of immune checkpoint blockers while mitigating immune-related adverse events. In our second research thrust\, we are developing a new nanoparticle platform for systemic delivery of STING (stimulator of IFN genes) agonists. While local STING activation can convert cold tumor into hot tumor\, it has been challenging to develop STING agonists that can treat disseminated cancer due to their toxicity. Here\, we will present our next-generation STING agonists that allow for systemic cancer therapy with potent efficacy\, favorable pharmaceutical properties\, and acceptable safety profiles in various murine and rabbit tumor models. Our biomaterial-based strategies may offer powerful and convenient approaches to regulate the immune system as potential therapies for cancer and other diseases.
URL:https://seasevents.nmsdev7.com/event/be-seminar-precision-engineering-for-cancer-immunotherapy-james-moon-university-of-michigan/
LOCATION:Glandt Forum\, Singh Center for Nanotechnology\, 3205 Walnut Street\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:Seminar
ORGANIZER;CN="Bioengineering":MAILTO:be@seas.upenn.edu
END:VEVENT
END:VCALENDAR